Tree Leaves as Bioindicator of Heavy Metal Pollution in Mechanic Village, Ogun State.

Metal contamination issues are becoming increasingly common in automobile workshop and elsewhere, Heavy metals, such as cadmium, copper, lead, are major environmental pollutants. Heavy metal accumulation in soils is of concern in agricultural production due to the adverse effects on food safety and marketability, crop growth due to phytotoxicity, and environmental health of soil organisms. Soil and plant samples were collected from mechanic village in Odeda local Government of Ogun State. The soil samples were collect at depth of 0-15cm and 15-30 cm, which are top soil and sub soil. The physiochemical parameters for soil were determined through the standard method and the heavy metal concentrations were determined using AAS. (Atomic Absorption Spectrometer). The EC range of the control farmland is 25 μS/cm- 195 μS/cm at 25oC while that of mechanic village ranges from 70 μS/cm-276 μS/cm at 25oC, the temperature of the farmland ranges from 27.8oC-28.0oC while that of the mechanic village ranges from 27.7oC-28.1oC. The pH of the farmland and mechanic village ranges from 6.47-7.67 and 6.48-7.79 respectively. The mean concentrations of the heavy metals in the soil of the farmland are in order of magnitude Cd>Cu>Pb, (0.62>0.018>0) while the mean concentration of the heavy metals in the soil of the mechanic village are in order of magnitude Pb>Cu>Cd (2.96>0.67>0.14) The mean concentration in leaf of farmland are Cu>Cd>Pb. (0.105>0.03>0.0001), while the mean concentration in mechanic village are Cu>Pb> Cd. (0.13>0.11> 0.02) the sudden rise of lead in mechanic village is understandable giving the various activities such as painting, welding, soldering and fueling which contain lead. Though the result indicate that they are not significant as they that are within the acceptable standard of FAO and WHO, 2010. © JASEMKeywords: Bioindicator, Contamination, Environmental Health, Heavy Metal, Phytotoxicit

An Assessment Of The Efficacy Of Dfmo In Baboons (Papio Anubis) Infected With Trypanosma Brucei Gambiense

Infection of four baboons with Trypanosma brucei gambiense resulted in a prepatent period of 3 – 4 days. Following the first appearance of T. b. gambiense parasitaemia, the animals developed trypanosomosis characterised by elevated parasite counts in the blood, fever, increased heart and respiratory rates and increased capillary refill time. The disease was also associated with pallor of visible mucous membranes, oedema, increased reticulocyte counts, progressive decline in erythrocyte indices (RBC, Hb and PCV), consistent monocytosis, and leucopenia due to lymphopenia and neutropenia. These clinical signs and widespread pathological changes seen in the liver, kidney, lymph nodes, heart and brain were progressive with the disease. The disease also disrupted the circadian rhythmicity of sleep and wakefulness between weeks 8 and 10 when the animals were in the classical diurnal sleepiness with 8 - 10 sleep episodes and nocturnal restlessness. All the infected baboons died from the attendant disease between the 8 and 10 weeks of infection. Treatment with Berenil or DFMO at 4 weeks post infection reversed most of the clinical, haematological and pathological changes, the CSF-WBC counts and cleared the parasites from the circulation of the infected baboons. However, there was relapse parasitaemia by 18 and 20 weeks respectively post infection in the groups treated with DFMO and Berenil. The results of this study suggest that baboons manifest similar clinical and pathological lesions as man infected with T. b. gambiense and might therefore be a useful model for the study of the human disease. Furthermore, the results suggest the therapeutic usefulness of DFMO in the treatment of human and animal trypanosomosis due to T. b. gambiense

Impact of management systems on selenium and zinc levels, heterophil: Lymphocyte ratio as biomarkers of immunity in chickens

This study investigated the impact of poultry management systems (intensive and extensive) on selenium and zinc concentrations and heterophil to lymphocyte ratio in chickens. Sixty chickens comprising 20 broilers, 20 local chickens and 20 layers obtained from poultry markets and houses around Ibadan, Oyo State, Nigeria were used in this study. Five millilitres of blood were collected through the brachial vein to analyse for selenium, zinc and complete blood count using atomic absorption spectrophotometry and standard haematological methods, respectively. There was a significantly (P<0.05) higher red blood cell, haemoglobin and pack cell volume values in local chickens raised in the extensive management system compared to broilers and layers raised in the intensive management system. There was no significant difference (P>0.05) in the white blood cell count between layers and local chickens. However, layers had higher white blood cell counts than local chickens. In contrast, local chickens had significantly (P<0.05) lower white blood cell count than broilers. The respective lymphocyte and heterophil counts were significantly (P<0.05) higher and lower in local chickens raised extensively compared to layers raised intensively. There were no significant differences (P>0.05) in monocyte, eosinophil and basophil count in chickens raised from both management systems. Chickens raised in the extensive management system had a significantly (P<0.05) higher selenium concentration with a lower heterophil to lymphocyte ratio than those raised in the intensive management system but had a significantly (P<0.05) lower zinc concentration. Therefore, high selenium levels and low heterophil to lymphocyte ratio could contribute to the resistance of chickens to various stressors associated with an extensive management system as selenium is a known immunomodulator

Chlamydial Infection, Plasma Peroxidation and Obesity in Tubal Infertility

Background: Genital tract infections and obesity are both sources of oxidative stress. Alterations in immune and antioxidant parameters may arise from this or from an indeterminate autoimmune mechanism.Objective: This study aimed to investigate the association of Chlamydial infection, obesity and oxidative response with tubal infertility in Nigerian women.Methods: It was a case-control study of 40 women with tubal infertility and 32 fertile women, respectively, recruited from the Infertility and Family Planning Clinics respectively, of the University College Hospital, Ibadan, Nigeria. Anthropometric indices were measured in each subject and endocervical swabs were taken to screen for current genital tract infection.Antioxidant, hormonal and immunologic analysis were performed on serum.Results: None of the subjects had current genital tract infections. Chlamydia trachomatis IgG positivity was significantly higher in infertile than in fertile subjects [OR 4.33; 95%CI (0.078-0.681)]. No significant variations were observed in the anthropometric indices, antioxidant parameters and hormones between infertile and the fertile women. Bodymass index correlated positively with oxidative stress in infertile subjects. Waist and hip circumferences correlated negatively with oestradiol in women with tubal infertility.Conclusion: Chlamydial infection is associated with tubal factor infertility, however, obesity seems to increase oxidative stress and reduce fertility potential in women with tubal factor infertility.Key words: Tubal infertility, obesity, oxidative stress, Chlamydi

The Effects of Storage on Sachet Water Quality in Ogun State, Nigeria

The purpose of this study is to investigate the effect of storage on the physicochemical status and bacteriological quality of sachet water produced and sold in  Abeokuta metropolis, Nigeria. Ten brands of sachet water were collected within 24 hours of production and stored at ambient temperature. Sub-samples were drawn from the stock samples immediately for physico-chemical and microbiological analyses and after two months. Physical parameters were determined by instrumental methods. Cationic and anionic constituents were determined by standard titrimetric and spectrophotometric methods, trace and heavy water were determined by Atomic Adsorption Spectrophotometer. The study revealed that all the brands of water analyzed were physically and chemically wholesome and met the WHO standards. Five brands (50%) of the water had total viable and coliform count above the recommended count of 100cfu/m and zero cfu/ml, respectively. pH values increased in all brands to acceptable WHO limits within 2 months of storage except for sample 3 and 4 which decreases below the acceptable limit.  Majorly dissolved oxygen and nitrate values decreased through the investigation period. Total and faecal coliform appeared in 50% of sachet water samples  analyzed immediately after production and were no longer detected after storing for two months except for sample 4. Results of the experiment indicate that 60% of the brands analyzed met the WHO guideline limit for drinking especially for the physico-chemical parameters while the majority failed in the microbiological essay when stored at ambient temperature for the two-month investigation period.KEYWORDS: Coliforms, Conductivity, Microbiological Assay, Physical and Chemical Parameters,Turbidity, Sachet Wate

Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain

Monoamines are involved in regulating the endogenous pain system and indeed, peripheral and central monoaminergic dysfunction has been demonstrated in certain types of pain, particularly in neuropathic pain. Accordingly, drugs that modulate the monaminergic system and that were originally designed to treat depression are now considered to be first line treatments for certain types of neuropathic pain (e.g., serotonin and noradrenaline (and also dopamine) reuptake inhibitors). The analgesia induced by these drugs seems to be mediated by inhibiting the reuptake of these monoamines, thereby reinforcing the descending inhibitory pain pathways. Hence, it is of particular interest to study the monoaminergic mechanisms involved in the development and maintenance of chronic pain. Other analgesic drugs may also be used in combination with monoamines to facilitate descending pain inhibition (e.g., gabapentinoids and opioids) and such combinations are often also used to alleviate certain types of chronic pain. By contrast, while NSAIDs are thought to influence the monoaminergic system, they just produce consistent analgesia in inflammatory pain. Thus, in this review we will provide preclinical and clinical evidence of the role of monoamines in the modulation of chronic pain, reviewing how this system is implicated in the analgesic mechanism of action of antidepressants, gabapentinoids, atypical opioids, NSAIDs and histaminergic drug

The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories:A systematic analysis for the Global Burden of Disease Study 2019

Importance Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is crucial for effective policy planning.Objective To analyze the total and risk-attributable burden of lip and oral cavity cancer (LOC) and other pharyngeal cancer (OPC) for 204 countries and territories and by Socio-demographic Index (SDI) using 2019 Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates.Evidence Review The incidence, mortality, and disability-adjusted life years (DALYs) due to LOC and OPC from 1990 to 2019 were estimated using GBD 2019 methods. The GBD 2019 comparative risk assessment framework was used to estimate the proportion of deaths and DALYs for LOC and OPC attributable to smoking, tobacco, and alcohol consumption in 2019.Findings In 2019, 370 000 (95% uncertainty interval [UI], 338 000-401 000) cases and 199 000 (95% UI, 181 000-217 000) deaths for LOC and 167 000 (95% UI, 153 000-180 000) cases and 114 000 (95% UI, 103 000-126 000) deaths for OPC were estimated to occur globally, contributing 5.5 million (95% UI, 5.0-6.0 million) and 3.2 million (95% UI, 2.9-3.6 million) DALYs, respectively. From 1990 to 2019, low-middle and low SDI regions consistently showed the highest age-standardized mortality rates due to LOC and OPC, while the high SDI strata exhibited age-standardized incidence rates decreasing for LOC and increasing for OPC. Globally in 2019, smoking had the greatest contribution to risk-attributable OPC deaths for both sexes (55.8% [95% UI, 49.2%-62.0%] of all OPC deaths in male individuals and 17.4% [95% UI, 13.8%-21.2%] of all OPC deaths in female individuals). Smoking and alcohol both contributed to substantial LOC deaths globally among male individuals (42.3% [95% UI, 35.2%-48.6%] and 40.2% [95% UI, 33.3%-46.8%] of all risk-attributable cancer deaths, respectively), while chewing tobacco contributed to the greatest attributable LOC deaths among female individuals (27.6% [95% UI, 21.5%-33.8%]), driven by high risk-attributable burden in South and Southeast Asia.Conclusions and Relevance In this systematic analysis, disparities in LOC and OPC burden existed across the SDI spectrum, and a considerable percentage of burden was attributable to tobacco and alcohol use. These estimates can contribute to an understanding of the distribution and disparities in LOC and OPC burden globally and support cancer control planning efforts

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic